BMRN vs XIFR · P/E 40, rev $1.76B vs rev $1.19B
Biomarin Pharmaceutical Inc (BMRN) versus XPLR Infrastructure LP Unit (XIFR) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
XPLR Infrastructure LP Unit (XIFR) is a utilities - renewable company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported XIFR revenue for 2025-12-31 was $1.19B. Net income was -$28.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. XIFR currently screens at market cap $814.0M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. XIFR currently screens at market cap $814.0M.
Not investment advice. Open the BMRN and XIFR stock pages for the full models.
Not investment advice.